CLINICAL SIGNIFICANCE OF THE DELAY IN STARTING SPECIAL TREATMENT FOR PATIENTS WITH SATGE III INOPERABLE NON-SMALL CELL LUNG CANCER: RESULTS OF STUDY AND LITERATURE REVIEW
Abstract
Introduction. Up to 30 % of patients with non-small cell lung cancer have locally advanced tumor. Increased waiting time for radiation therapy and/or chemotherapy can result in tumor progression and impaired survival.
The purpose of the study was to evaluate the influence of the length of time before starting therapy on the overall survival in patients with inoperable locally advanced non-small cell lung cancer.
Materials and methods. In the retrospective study, 139 patients with non-small cell lung cancer, receiving chemoradiotherapy were divided into subgroups by the length of time before starting therapy. The overall survival was assessed using the Kaplan-Meier method with determination of differences between groups by long-rank test, and the cumulative overall survival was compared using the χ2 test. The Cox regression model was applied to evaluate the effect of covariates on overall survival.
Results. Chemoradiotherapy was started within 1 month after diagnosis in 87 (63 %) patients and in 31 days and later in 52 (37 %) patients. Distribution by initial prognostic factors was uniform, except for exploratory thoracotomy, which was performed more often in patients who received chemotherapy within 1 month after diagnosis (р=0.001). The median overall survival rate was 14.2 months (95 % CI: 11.8–16.7) for patients who received chemoradiotherapy within 1 month after diagnosis and 19.1 months (95 % CI: 14.7–23.5) for patients, who received therapy at least 1 months after diagnosis (χ2 =0.562, р=0.453). Risk ratio (RR) of death was 0.87 (95 % CI: 0.59–1.26) in patients with late onset of special treatment.
Conclusion. The retrospective analysis showed that time before onset of chemoradiotherapy in patients with stage III non-small cell lung cancer had no influence on prognosis of survival, with the initial chemotherapy as well as radiotherapy. These results require confirmation in randomized trials.
About the Authors
Е. P. Solovyeva
Arkhangelsk Clinical Cancer Center, Arkhangelsk
Northern State Medical University, Arkhangelsk
Russian Federation
51, Troitskiy per., 163000-Arkhangelsk
Russian Federation
51, Troitskiy per., 163000-Arkhangelsk
S. М. Asakhin
Arkhangelsk Clinical Cancer Center, Arkhangelsk
Northern State Medical University, Arkhangelsk
Russian Federation
51, Troitskiy per., 163000-Arkhangelsk
Russian Federation
51, Troitskiy per., 163000-Arkhangelsk
М. Yu. Valkov
Arkhangelsk Clinical Cancer Center, Arkhangelsk
Northern State Medical University, Arkhangelsk
Russian Federation
51, Troitskiy per., 163000-Arkhangelsk
Russian Federation
51, Troitskiy per., 163000-Arkhangelsk
References
1. Давыдов М.И, Аксель Е.М. Заболеваемость злокачественными новообразованиями населения России и стран СНГ в 2007 г. // Вестник РОНЦ им. Н.Н. Блохина РАМН. 2009. № 20 (3s). С. 52–90.
2. Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2012 году. М., 2013. С. 20–95.
3. Красильников А.В., Потехина Е.Ф. Состояние онкологической помощи населению Архангельской области в 2012 году // Оптимизация лечебно-диагностической тактики при онкологических заболеваниях: Материалы научно-практической конференции. Архангельск, 2013. С. 8–58.
4. Онкология. Справочник практического врача / Под ред. И.В. Поддубной. М.: МЕДпресс-информ, 2009. 768 с.
5. Соловьева Е.П., Кононова Г.В., Вальков М.Ю. Выбор очередности методов консервативного лечения неоперабельного немелкоклеточного рака легкого III стадии: ретроспективный анализ выживаемости // Вестник РНЦРР. 2012. № 12. http://www.vestnik.rncrr.ru/vestnik/v12/ papers/solo_v12.htm
6. Aupérin А., Le Péchoux С., Rolland E., Curran W., Furuse К., Fournel Р., Belderbos J., Clamon G., Ulutin H.C., Paulus R., Yamanaka T., Bozonnat M.C., Uitterhoeve A., Wang X., Stewart L., Arriagada R., Burdett S., Pignon J.P. Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer. // J. Clin. Oncol. 2010. Vol. 28. P. 2181–2190. doi: 10.1200/JCO.2009.26.2543.
7. Bozcuk H., Martin C. Does treatment delay affect survival in nonsmall cell lung cancer? A retrospective analysis from a single UK centre // Lung Cancer. 2001. Vol. 34. P. 243–252.
8. Butof R., Baumann M. Time in radiation oncology – keep it short! // J. Radiother. Oncol. 2013. Vol. 106 (3). P. 271–275. doi: 10.1016/j. radonc.2013.03.007.
9. Christensen E.D., Harvald T., Jendresen M., Aggestrup S., Petterson G. The impact of delayed diagnosis of lung cancer on the stage at the time of operation // Eur. J. Cardiothorac. Surg. 1997. Vol. 12. P. 880–884.
10. De Ruysscher D., Botterweck A., Dirx M., Pijls-Johannesma M., Wanders R., Hochstenbag M., Dingemans A.M., Bootsma G., Geraedts W., Simons J., Pitz C., Lambin P. Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study // Ann. Oncol. 2009. Vol. 20. Issue 1. P. 98–102. doi: 10.1093/annonc/mdn559.
11. El Sharouni S.Y., Kal H.B., Battermann J.J. Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy // Br. J. Cancer. 2003. Vol. 89. P. 2184–2189.
12. Etiz D., Marks L.B., Zhou S.M., Bentel G.C., Clough R., Hernando M.L., Lind P.A. Influence of tumor volume on survival in patients irradiated for non-small-cell lung cancer // Int. J. Radiat. Oncol. Biol. Phys. 2002. Vol. 53. P. 835–846.
13. Falk S.J., Girling D.J., White R.J., Hopwood P., Harvey A., Qian W., Stephens R.J. Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial // BMJ. 2002. Vol. 325. P. 465.
14. Geddes D.M. The natural history of lung cancer: a review based on rates of tumour growth // Br. J. Dis. Chest. 1979. Vol. 73. P. 1–17.
15. Hasegawa M., Sone S., Takashima S., Li F., Yang Z.G., Maruyama Y., Watanabe T. Growth rate of small lung cancers detected on mass CT screening // Br. J. Radiol. 2000. Vol. 73. P. 1252–1259.
16. Jensen A.R., Mainz J., Overgaard J. Impact of delay on diagnosis and treatment of primary lung cancer // Acta Oncol. 2002. Vol. 41. P. 147–152.
17. Koyi H., Hillerdal G., Branden E. Patient’s and doctors’ delays in the diagnosis of chest tumors // Lung Cancer. 2002. Vol. 35. P. 53–57.
18. Liberman M., Liberman D., Sampalis J.S., Milder D.S. Delays to surgery in non-small-cell lung cancer // Can. J. Surg. 2006. Vol. 49. P. 31–36.
19. Mackillop W.J., Bates J.H., O’Sullivan B., Withers H.R. The effect of delay in treatment on local control by radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 1996. Vol. 34. P. 243–250.
20. Myrdal G., Lambe M., Hillerdal G., Lamberg K., Agustsson Th., Stahle E. Effect of delays on prognosis in patients with non-small cell lung cancer // Thorax. 2004. Vol. 59. P. 45–49.
21. O’Rourke N., Edwards R. Lung cancer treatment waiting times and tumour growth // Clin. Oncol. (R. Coll. Radiol.). 2000. Vol. 12. P. 141–144.
22. Robinson E., Mohilever J., Zidan J., Sapir D. Delay in diagnosis of cancer. Possible effects on the stage of disease and survival // Cancer. 1984. Vol. 54. P. 1454–1460.
23. The diagnosis and treatment of lung cancer (update): full guideline (January 2011) 227 p. Available at: http://www.nice.org.uk/nicemedia/ live/11885/53195/53195.pdf.
24. Wang Li, Correa C.R., Hayman A.J., Zhao L., Cease K., Brenner D., Arenberg D., Curtis J., Kalemkerian G.P., Kong F.M. Time to Treatment in Patients with Stage III Non-Small Cell Lung Cancer // Int. J. Radiat. Oncol. Biol. Phys. 2009. Vol. 74. P. 790–795. doi: 10.1016/j.ijrobp.2008.08.039.
25. Willner J., Baier K., Caragiani E., Tschammler A., Flentje M. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer // Int. J. Radiat. Oncol. Biol. Phys. 2002. Vol. 52. P. 382–389.
Review
For citations:
Solovyeva Е.P., Asakhin S.М., Valkov М.Yu. CLINICAL SIGNIFICANCE OF THE DELAY IN STARTING SPECIAL TREATMENT FOR PATIENTS WITH SATGE III INOPERABLE NON-SMALL CELL LUNG CANCER: RESULTS OF STUDY AND LITERATURE REVIEW. Siberian journal of oncology. 2014;(3):11-18. (In Russ.)
Views:
572
Email this article 
